Shufro Rose & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Shufro Rose & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$338K	Sell	2,650 -100	-4%	-$12.5K	0.02%	227
2025 Q4	$335K	Sell	2,750 -200	-7%	-$22.9K	0.02%	222
2025 Q3	$239K	Hold	2,950	–	–	0.02%	264
2025 Q2	$239K	Hold	2,950	–	–	0.02%	261
2025 Q1	$239K	Hold	2,950	–	–	0.02%	264
2024 Q4	$266K	Sell	2,950 -1,967	-40%	-$191K	0.02%	240
2024 Q3	$456K	Hold	4,917	–	–	0.04%	184
2024 Q2	$456K	Sell	4,917 -75	-2%	-$6.72K	0.04%	184
2024 Q1	$474K	Buy	4,992 +1,817	+57%	+$169K	0.04%	182
2023 Q4	$232K	Hold	3,175	–	–	0.02%	251
2023 Q3	$232K	Hold	3,175	–	–	0.02%	250
2023 Q2	$264K	Hold	3,175	–	–	0.02%	241
2023 Q1	$242K	Sell	3,175 -4,669	-60%	-$387K	0.02%	252
2022 Q4	$651K	Sell	7,844 -525	-6%	-$42.5K	0.05%	144
2022 Q3	$664K	Hold	8,369	–	–	0.07%	135
2022 Q2	$622K	Hold	8,369	–	–	0.05%	150
2022 Q1	$752K	Sell	8,369 -300	-3%	-$27.7K	0.06%	145
2021 Q4	$971K	Hold	8,669	–	–	0.07%	127
2021 Q3	$1.09M	Buy	8,669 +300	+4%	+$38.6K	0.09%	110
2021 Q2	$1.13M	Buy	8,369 +225	+3%	+$29.6K	0.09%	107
2021 Q1	$1.1M	Sell	8,144 -200	-2%	-$29.9K	0.09%	105
2020 Q4	$1.18M	Sell	8,344 -300	-3%	-$38.4K	0.1%	100
2020 Q3	$963K	Buy	8,644 +139	+2%	+$15.6K	0.09%	104
2020 Q2	$952K	Buy	8,505 +5	+0.1%	+$492	0.09%	99
2020 Q1	$658K	Buy	8,500 +200	+2%	+$17.7K	0.08%	120
2019 Q4	$789K	Hold	8,300	–	–	0.07%	132
2019 Q3	$633K	Sell	8,300 -100	-1%	-$8.31K	0.06%	141
2019 Q2	$737K	Hold	8,400	–	–	0.07%	131
2019 Q1	$761K	Hold	8,400	–	–	0.08%	130
2018 Q4	$603K	Hold	8,400	–	–	0.07%	149
2018 Q3	$805K	Sell	8,400 -1,000	-11%	-$97K	0.07%	138
2018 Q2	$895K	Hold	9,400	–	–	0.09%	129
2018 Q1	$825K	Sell	9,400 -100	-1%	-$9.13K	0.08%	130
2017 Q4	$806K	Sell	9,500 -200	-2%	-$16.8K	0.08%	136
2017 Q3	$840K	Hold	9,700	–	–	0.08%	133
2017 Q2	$749K	Sell	9,700 -200	-2%	-$14.2K	0.08%	128
2017 Q1	$686K	Sell	9,900 -300	-3%	-$20.1K	0.07%	139
2016 Q4	$604K	Sell	10,200 -300	-3%	-$18.5K	0.07%	141
2016 Q3	$696K	Sell	10,500 -900	-8%	-$55.7K	0.08%	129
2016 Q2	$617K	Sell	11,400 -300	-3%	-$16.4K	0.07%	144
2016 Q1	$604K	Hold	11,700	–	–	0.07%	148
2015 Q4	$821K	Hold	11,700	–	–	0.09%	126
2015 Q3	$728K	Hold	11,700	–	–	0.09%	132
2015 Q2	$983K	Hold	11,700	–	–	0.1%	120
2015 Q1	$879K	Hold	11,700	–	–	0.09%	128
2014 Q4	$727K	Hold	11,700	–	–	0.07%	139
2014 Q3	$608K	Sell	11,700 -600	-5%	-$30.6K	0.06%	157
2014 Q2	$631K	Sell	12,300 -600	-5%	-$27.1K	0.06%	155
2014 Q1	$612K	Sell	12,900 -600	-4%	-$30.7K	0.06%	154
2013 Q4	$585K	Sell	13,500 -2,100	-13%	-$86.9K	0.06%	154
2013 Q3	$671K	Hold	15,600	–	–	0.08%	131
2013 Q2	$542K	Buy	+15,600	New	+$548K	0.06%	146

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Shufro Rose & Co's XBI Position: Q1 2026 in Review

Shufro Rose & Co reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3.6% in Q1 2026, selling an estimated $12.5K and leaving 2,650 shares worth $338K. The position accounts for 0.02% of the portfolio, ranked #227.

Shufro Rose & Co first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.18M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Shufro Rose & Co held 2,650 shares of State Street SPDR S&P Biotech ETF worth $338K as of Q1 2026.
Shufro Rose & Co sold 100 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $12.5K.
State Street SPDR S&P Biotech ETF made up 0.02% of Shufro Rose & Co's portfolio in Q1 2026, its #227 holding.
Shufro Rose & Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
Shufro Rose & Co's State Street SPDR S&P Biotech ETF position peaked at $1.18M in Q4 2020.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.